Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lin Li, Yuwei Zhang, Yudan Luo, Xianghui Meng, Guixiang Pan, Han Zhang, Yuhong Li & Boli Zhang. (2023) The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications. Drug Design, Development and Therapy 17, pages 771-790.
Read now
Read now
Qiuning Wang, Weiying Chen, Xuefeng Yang, Ying Song, Xiaowei Sun, Guizhou Tao, Hong Wang, Nan Zhao, Yue Huang, Erqing Chai & Futian Tang. (2022) Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats. Journal of Inflammation Research 15, pages 2617-2629.
Read now
Read now
Xiaoqing Zhang, Huiyan Qu, Tao Yang, Qian Liu & Hua Zhou. (2022) Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway. Cell Cycle 21:21, pages 2309-2322.
Read now
Read now
Wei Yan, Yao Xu, Yanhong Yuan, Lei Tian, Qin Wang, Yuanyuan Xie, Xinghua Shao, Ming Zhang, Zhaohui Ni & Shan Mou. (2017) Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury. Free Radical Research 51:7-8, pages 669-683.
Read now
Read now
Jinfeng Li, Lifeng Huang, Shuzhen Wang, Yongming Yao & Zhenyu Zhang. (2016) Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice. Pharmaceutical Biology 54:12, pages 3217-3225.
Read now
Read now
Articles from other publishers (30)
Chunkun Yang, Qingquan Pan, Kui Ji, Zhuang Tian, Hongyuan Zhou, Shuanghong Li, Chuanchao Luo & Jun Li. (2023) Review on the protective mechanism of astragaloside IV against cardiovascular diseases. Frontiers in Pharmacology 14.
Crossref
Crossref
Lin Zhang, Bin Li, Wei Li, Jingbo Jiang, Wei Chen, Huayun Yang & Diguang Pan. (2023) miR-107 Attenuates Sepsis-Induced Myocardial Injury by Targeting PTEN and Activating the PI3K/AKT Signaling Pathway. Cells Tissues Organs 212:6, pages 523-534.
Crossref
Crossref
Maria Theresa Voelker, Nadine Hechaichi, Bernadin Ndongson-Dongmo, Jana Lemm, Regine Heller, Reinhardt Bauer, Edward M. Conway, Gregor Theilmeier & Sebastian N. Stehr. (2022) Role of the lectin-like domain of thrombomodulin in septic cardiomyopathy. Life Sciences 306, pages 120830.
Crossref
Crossref
Goutami G. Ambati, Kamalender Yadav, Ruchika Maurya, K.K. Kondepudi, Mahendra Bishnoi & Sanjay M. Jachak. (2022) Evaluation of the in vitro and in vivo anti-inflammatory activity of Gymnosporia montana (Roth). Benth leaves. Journal of Ethnopharmacology 297, pages 115539.
Crossref
Crossref
Danial Taherzadeh, Vafa Baradaran Rahimi, Hamed Amiri, Sajjad Ehtiati, Roghayeh Yahyazadeh, Seyed Isaac Hashemy & Vahid Reza Askari. (2022) Acetyl-11-Keto-β-Boswellic Acid (AKBA) Prevents Lipopolysaccharide-Induced Inflammation and Cytotoxicity on H9C2 Cells. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-10.
Crossref
Crossref
Xin Huang, Min-zhou Zhang, Bo Liu, Shi-yu Ma, Xin Yin & Li-heng Guo. (2021) Astragaloside IV Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction in Rats via IKK/NF-κB Pathway. Chinese Journal of Integrative Medicine 27:11, pages 825-831.
Crossref
Crossref
Afsaneh Bagherzadeh, Hamidreza Vaziri, Fatemeh Sokouti Nasimi, Shahin Ahmadian, Adel Feyzi, Mehrdad Farhadi, Fariba Yahyavi, Behnam Hashemi, Reza Rahbarghazi & Mahdi Mahdipour. (2021) Bacterial Lipase Neutralized Toxicity of Lipopolysaccharide on Chicken Embryo Cardiac Tissue. Cardiovascular Toxicology 21:7, pages 582-591.
Crossref
Crossref
Hui‐fei Su, Sharpkate Shaker, Yi Kuang, Meng Zhang, Min Ye & Xue Qiao. (2021) Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix). Medicinal Research Reviews 41:4, pages 1999-2038.
Crossref
Crossref
Jie Sun, Shanzhai Wei, Yilai Zhang & Jia Li. (2021) Protective Effects of Astragalus Polysaccharide on Sepsis-Induced Acute Kidney Injury. Analytical Cellular Pathology 2021, pages 1-13.
Crossref
Crossref
Shufang Hu, Weihong Zheng & Li Jin. (2020) Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1. Journal of Natural Medicines 75:1, pages 156-166.
Crossref
Crossref
Ruirui Lu, Junqi Chen, Bihao Liu, Hua Lin, Lixia Bai, Peichun Zhang, Dandan Chen, Honglian Li, Jicheng Li, Yu Pang, Yuan Zhou, Jiuyao Zhou & Junbiao Wu. (2020)
Protective role of Astragaloside
IV
in chronic glomerulonephritis by activating autophagy through
PI3K
/
AKT
/
AS160
pathway
. Phytotherapy Research 34:12, pages 3236-3248.
Crossref
Crossref
Ekaterina Proshkina, Sergey Plyusnin, Tatyana Babak, Ekaterina Lashmanova, Faniya Maganova, Liubov Koval, Elena Platonova, Mikhail Shaposhnikov & Alexey Moskalev. (2020) Terpenoids as Potential Geroprotectors. Antioxidants 9:6, pages 529.
Crossref
Crossref
Yan-gu Tao, Xiu-Fang Huang, Jun-yan Wang, Meng-ru Kang, Ling-jun Wang & Shao-xiang Xian. (2020) Exploring Molecular Mechanism of Huangqi in Treating Heart Failure Using Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-17.
Crossref
Crossref
Shuhua Xie, Tao Yang, Zhifen Wang, Man Li, Ling Ding, Xiaotong Hu & Licheng Geng. (2020) Astragaloside IV attenuates sepsis-induced intestinal barrier dysfunction via suppressing RhoA/NLRP3 inflammasome signaling. International Immunopharmacology 78, pages 106066.
Crossref
Crossref
Suxiao Wu & Zilan Chen. (2019) Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo. Experimental and Therapeutic Medicine.
Crossref
Crossref
Yong Luo, Qing Wan, Min Xu, Qing Zhou, Xuepiao Chen, Dong Yin, Huan He & Ming He. (2019) Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function. Chemico-Biological Interactions 309, pages 108723.
Crossref
Crossref
Jianping Liu, Jianhua Li, Peigang Tian, Bahaer Guli, Guopeng Weng, Lei Li & Qinghong Cheng. (2019) H2S attenuates sepsis‑induced cardiac dysfunction via a PI3K/Akt‑dependent mechanism. Experimental and Therapeutic Medicine.
Crossref
Crossref
He Bao, Danyu Sun, Peng Qi & Shixian Jiang. (2019) RETRACTED: Astragaloside protects oxygen and glucose deprivation induced injury by regulation of microRNA-21 in retinal ganglion cell line RGC-5. Biomedicine & Pharmacotherapy 109, pages 1826-1833.
Crossref
Crossref
Bingshu He, Zhonghua Wang, Lulu Chen, Zhi Zhou & Zeper Abliz. (2018) A rapid, sensitive, and selective liquid chromatography–mass spectrometry method for simultaneous quantification of astragaloside IV and cycloastragenol in mouse plasma and its application to a pharmacokinetic study. International Journal of Mass Spectrometry 434, pages 130-135.
Crossref
Crossref
Bin Tang, Jin-Guo Zhang, Hong-Yong Tan & Xi-Qing Wei. (2018) Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure. Bioscience Reports 38:3.
Crossref
Crossref
Yaling Li, Yun Ye & Hongyan Chen. (2018) Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB. Biomedicine & Pharmacotherapy 99, pages 134-141.
Crossref
Crossref
Guizhi Jia, Bin Leng, Hongxin Wang & Hongliang Dai. (2017) Inhibition of cardiotrophin-1 overexpression is involved in the anti-fibrotic effect of Astrogaloside IV. Molecular Medicine Reports 16:6, pages 8365-8370.
Crossref
Crossref
Qiang Zhang, Jingjing Huang, Junping Yu, Zhongmin Xu, Liang Liu, Yajing Song, Xiaomei Sun, Anding Zhang & Meilin Jin. (2017) HP1330 Contributes to Streptococcus suis Virulence by Inducing Toll-Like Receptor 2- and ERK1/2-Dependent Pro-inflammatory Responses and Influencing In Vivo S. suis Loads. Frontiers in Immunology 8.
Crossref
Crossref
Hongliang Dai, Guizhi Jia, Meili Lu, Chunguang Liang, Yue Wang & Hongxin Wang. (2017) Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis. Molecular Medicine Reports.
Crossref
Crossref
Liu Xianchu, Professor Zheng Lan, Li Qiufang, Liu Yi, Ruan Xiangcheng, Hou Wenqi & Ding Yang. (2016) Naringin protects against lipopolysaccharide-induced cardiac injury in mice. Environmental Toxicology and Pharmacology 48, pages 1-6.
Crossref
Crossref
Huili Sun, Wenjing Wang, Pengxun Han, Mumin Shao, Gaofeng Song, Heng Du, Tiegang Yi & Shunmin Li. (2016) Astragaloside IV ameliorates renal injury in db/db mice. Scientific Reports 6:1.
Crossref
Crossref
Birgit Waltenberger, Andrei Mocan, Karel Šmejkal, Elke Heiss & Atanas Atanasov. (2016) Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders. Molecules 21:6, pages 807.
Crossref
Crossref
RONGFENG ZHU, JIANJUN ZHENG, LIZHEN CHEN, BIN GU & SHENGLI HUANG. (2016) Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway. International Journal of Molecular Medicine 37:6, pages 1697-1705.
Crossref
Crossref
Maria Theresa Voelker, Nadine Hechaichi, Bernadin Ndongson-Dongmo, Jana Lemm, Regine Heller, Reinhardt Bauer, Edward M. Conway, Gregor Theilmeier & Sebastian Stehr. (2022) Role of the Lectin-Like Domain of Thrombomodulin in Septic Cardiomyopathy. SSRN Electronic Journal.
Crossref
Crossref
Maria Theresa Voelker, Nadine Hechaichi, Bernadin Ndongson-Dongmo, Jana Lemm, Regine Heller, Reinhardt Bauer, Edward M. Conway, Gregor Theilmeier & Sebastian N. Stehr. (2022) Role of the Lectin-Like Domain of Thrombomodulin in Septic Cardiomyopathy Thrombomodulin in Septic Cardiomyopathy. SSRN Electronic Journal.
Crossref
Crossref